Previous Article | Next Article ![]()
Applied and Environmental Microbiology, January 2007, p. 179-185, Vol. 73, No. 1
0099-2240/07/$08.00+0 doi:10.1128/AEM.01763-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Department of Pharmaceutical Sciences, University of Bologna, Bologna, Italy,1 Department of Chemistry, University of Modena and Reggio Emilia, Modena, Italy2
Received 26 July 2006/ Accepted 13 October 2006
|
|
|---|
|
|
|---|
Folate is widely distributed in the biological world, intestinal bacteria being one source of this vitamin. It has been demonstrated that folate synthesized by bacteria in the human intestine is absorbed and used by the host (4, 8, 13, 14, 18); however, little is known about folate production by the intestinal microbiota. Some information is available about the parameters, such as external pH, dilution rate, and p-aminobenzoic (PABA) concentration, that influence folate production by lactic acid and starter bacteria used for the production of yogurt, probiotic dairy products, and cheeses (5, 15, 23). Moreover, efforts to increase the production of naturally bioavailable folate by Lactococcus lactis during food fermentation have been successful (22, 24, 25). It has also been shown that increased folate levels in yogurts and fermented milks are possible through judicious selection of the inoculum species; nevertheless, these folate levels remain relatively low in terms of the recommended daily allowance (5).
The present work investigated folate production by bifidobacteria. Bifidobacteria are gram-positive, saccharolytic, intestinal anaerobes. They acidify the large intestine, restricting putrefactive and potentially pathogenic bacteria; produce vitamins and amino acids; stimulate the immune response; repress the conversion of primary bile salts; exert anti-inflammatory activity; and reduce the risk of colon cancer (19, 26, 27). Because of these beneficial health effects, bifidobacteria are generally considered probiotic organisms and are increasingly being used in functional foods and pharmaceutical products. Nevertheless, there is limited information concerning folate production by bifidobacteria; knowledge is limited to the demonstration of diverse folate concentrations after the growth of seven Bifidobacterium strains in skim milk (5).
Most folate absorption occurs through the jejunum, but it has been demonstrated that folate produced by colonic microorganisms can be absorbed across the large intestine (4, 29). The aim of this study was to select bifidobacterial strains that combine the intrinsic probiotic activities of the genus Bifidobacterium with significant production of folic acid, in order to supply proliferating colonocytes with this vitamin.
|
|
|---|
Chemicals and media.
All chemicals were obtained from Sigma-Aldrich (Steinheim, Germany) unless otherwise stated.
Folate production in pure Bifidobacterium cultures was tested in the folate-free semisynthetic medium (SM) SM7. SM7 is based on SM (16) with modifications: Bacto vitamin assay Casamino Acids (Difco) was used, and yeast nitrogen base (Difco) was replaced with pyridoxine (2 mg liter1), nicotinic acid (2 mg liter1), thiamine (2 mg liter1), calcium pantothenate (1 mg liter1), riboflavin (1 mg liter1), PABA (0.05 mg liter1), and biotin (0.05 mg liter1). The pH was adjusted to 7.0, and the medium was autoclaved for 30 min at 110°C. Glucose was autoclaved separately and added to the sterile basal medium to obtain a concentration of 20 g liter1. Fecal cultures were carried out in the medium FM7, which is based on the complex medium described by Rycroft et al. (17) with modifications: yeast extract was replaced with PABA (0.45 mg liter1), biotin (0.45 mg liter1), pyridoxine (18 mg liter1), nicotinic acid (18 mg liter1), thiamine (18 mg liter1), calcium pantothenate (9 mg liter1), riboflavin (9 mg liter1), and fructans (10g liter1) (Raftilose Synergy, Orafti, Tienen, Belgium) as carbon sources. The pH was adjusted to 7.0, and the medium was autoclaved for 30 min at 110°C.
Culture conditions.
Bifidobacterium strains were subcultured in Lactobacilli MRS broth (Difco) containing 0.5 g liter1 L-cysteine · HCl and were anaerobically incubated at 37°C for 24 h. Cells from the MRS cultures were inoculated (5%, vol/vol) into 10 ml of SM7; SM7 cultures were incubated anaerobically at 37°C for 48 h.
The growth of Bifidobacterium strains and production of intracellular and extracellular folate were assayed in liquid cultures of SM7. To determine whether exogenous folate down-regulated production, the folate concentration was determined in cultures grown in SM7 supplemented with 10, 25, 50, and 100 µg liter1 vitamin. In order to evaluate the effect of PABA concentration on folate biosynthesis, the folate concentration was determined in cultures grown in SM7 containing 0, 0.1, 1, 10, or 100 µM PABA. Cultures were always propagated at least seven times in the same medium before the measurement of folate concentrations in the supernatants or cell extracts. Growth was determined by measuring the final pH and optical density at 600 nm (OD600).
pH-controlled batch cultures were performed in SM7 in a 2-liter-working-volume BM-PPS3 bioreactor (Bioindustrie Mantovane, Porto Mantovano, Italy). The temperature was kept constant at 37°C. The pH was continuously measured (Mettler Toledo InPro 3030/325) and kept constant by the automatic addition of 4 M NaOH. Anaerobiosis (<5 ppm oxygen) was maintained by sparging of the culture with 0.05 vol/vol/min filter-sterilized nitrogen (Millex filter type GS, 33 mm). The culture was constantly stirred at 300 rpm. The fermenter was inoculated (10%, vol/vol) with exponential-phase precultures grown in the same medium. Samples were periodically collected for dry weight measurement and folate analysis.
Anaerobic chemostat cultivation was carried out in 1 liter of SM7 at a dilution rate of 0.075 h1 without control of the pH. The fresh medium was anaerobically maintained by the flushing of filter-sterilized CO2 into the headspace of the feeding tank. The fermentation was initiated batchwise by directly inoculating the grown seed culture in the fermenter. At minimum, five residence times were allowed to elapse, and steady state was considered attained when the pH and biomass concentration remained constant for at least two residence times. Steady-state samples were collected for biomass measurement and folate analysis. The effect of different carbon sources on folate production was studied in continuous fermentations wherein the glucose of SM7 was replaced by lactose, fructose, raffinose, or fructans. All fermentations were carried out in duplicate.
To prepare fecal cultures, fresh feces were obtained from seven healthy volunteers (four men and three women) who had followed a pre/probiotic-free diet for 1 month and had not been treated with antibiotics for at least 3 months. All preparations were done in an anaerobic cabinet (Anaerobic System; Forma Scientific Co., Marietta, GA) under an atmosphere of 85% N2, 10% CO2, and 5% H2. Fecal samples were anaerobically resuspended (10%, wt/vol) in 0.1 M phosphate buffer, pH 7.0, and pasteurized at 80°C for 15 min. Fecal suspension was added (10%, vol/vol) to FM7 anaerobic serum bottles. Then, fecal cultures were inoculated (5%, vol/vol) with a 24-h culture of B. adolescentis MB 239 grown in SM7 or, as a negative control, with the same volume of sterile SM7. Fecal cultures were incubated at 37°C, and samples were collected for folate analysis at 0 and 48 h.
Folate analysis.
The folate concentration was assayed on cell extracts and culture supernatants. Thirty-milliliter cultures were centrifuged at 13,000 x g for 10 min at 0°C. The supernatant was filtered through a 0.22-µm-pore-size filter. The biomass was washed with 0.05 M K-phosphate buffer, pH 6.5, and the wet pellet was resuspended 1:1 (wt/vol) in the same buffer. Then, 0.5-g glass beads (
106 µm) (Sigma-Aldrich) were added to a 1-ml suspension, and cells were disrupted at 1,800 rpm for 10 min at 4°C in a vibration homogenizer (MS1; IKA, Wilmington, NC). The cell extract was heated at 100°C for 3 min to release folate from folate binding proteins and to precipitate proteins, and then it was centrifuged (13,000 x g, 15 min, 4°C) and filtered (0.22-µm-pore-size filter).
The folate concentration was analyzed with a microbiological bioassay (7, 12). For the bioassay, Bacto folic acid assay medium (Difco) was used with Enterococcus hirae ATCC 8043 as the test organism, according to the protocol described by the medium manufacturer. The total folate concentration, including polyglutamyl folate, was analyzed after the samples were treated with human plasma (Sigma-Aldrich), as a source of
-glutamyl hydrolase activity, at 37°C and pH 4.8 for 4 h. Microbiological assay measurements were replicated at least 10 times.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Species and origins of 76 Bifidobacterium strains screened for the ability to grow in SM7a
|
![]() View larger version (14K): [in a new window] |
FIG. 1. Intracellular and extracellular folate concentrations in 48-h cultures of B. adolescentis MB 114, MB 115, MB 227, and MB 239 and B. pseudocatenulatum MB 116 and MB 237. Mean values from three separate experiments are reported; SDs were always less than 3.0 ng ml1.
|
![]() View larger version (33K): [in a new window] |
FIG. 2. Net extracellular folate production in 48-h cultures of B. adolescentis MB 114, MB 115, MB 227, and MB 239 and B. pseudocatenulatum MB 116 and MB 237 in SM7 supplemented with 0, 10, 25, or 50 ng ml1 folate. Mean values from three separate experiments are reported; SDs were always less than 4.0 ng ml1.
|
![]() View larger version (26K): [in a new window] |
FIG. 3. Extracellular folate concentrations in 48-h cultures of B. adolescentis MB 114, MB 115, MB 227, and MB 239 and B. pseudocatenulatum MB 116 and MB 237 in SM7 supplemented with 0, 0.3, 10, or 100 µM PABA. Mean values from three separate experiments are reported; SDs were always less than 3.0 ng ml1.
|
0.05).
![]() View larger version (13K): [in a new window] |
FIG. 4. Batch fermentation of B. adolescentis MB 239 in SM7 with controlled pH (6.5). Symbols: , DW, (dry weight); , extracellular folate concentration.
|
0.05), excluding any relationship between carbon source and folate productivity.
Production of folate by B. adolescentis MB 239 in fecal cultures.
Fecal cultures were inoculated with 24-h cultures of B. adolescentis MB 239 in order to study whether the strain could grow and produce folate in a medium that resembled fecal composition. The folate concentration was measured after inoculation of B. adolescentis MB 239 at 0 and 48 h of anaerobic incubation at 37°C. Uninoculated fecal cultures were used as negative controls. To evaluate the net contribution of B. adolescentis MB 239 to folate concentration, fecal material was pasteurized in order to prevent fecal bacteria from producing or absorbing folate.
Fecal bottles that were not inoculated with B. adolescentis MB 239 showed no change in folate concentration (27.0 ng ml1 [standard deviation {SD}, 8.2 ng ml1] and 28.3 ng ml1 [SD, 11.9 ng ml1] at 0 and 48 h, respectively), whereas the presence of B. adolescentis MB 239 led to a significant increase in vitamin concentration, from 28.3 ng ml1 (SD, 11.9 ng ml1) to 52.8 ng ml1 (SD, 1.8 ng ml1).
|
|
|---|
Our study provided results rather different from those of previous studies. Deguchi et al. actually regarded B. adolescentis and B. longum as low-folic-acid producers and B. bifidum and B. infantis as high-folic-acid producers (6). In other studies, the highest folate accumulations in reconstituted skim milk differed after incubation with strains of B. breve and B. infantis (6) or B. longum (15). Such discrepancies may be due both to strain-to-strain differences and to different experimental designs. Folate-free media had never been used in previous studies; in this work, cultures were passaged seven times in folate-free medium to evaluate growth and folate production.
In the human intestinal tract, bifidobacteria are exposed to exogenous folate, the concentration range of which can be rather large depending on vitamin intake and absorption and excretion from urine, skin, and bile (3). To clarify whether exogenous vitamin affected productivity, bifidobacteria were cultivated in the presence of folate in a range between 0 and 50 ng ml1. Folate production by B. adolescentis MB 114 and MB 115 and B. pseudocatenulatum MB 116 was negatively affected by high exogenous folate concentrations, whereas no feedback effects were observed for B. adolescentis MB 227, B. adolescentis MB 239, or B. pseudocatenulatum MB 237. It is conceivable that folate biosynthesis by these strains is not regulated, considering that the final concentrations were at least 50-fold higher than the requirement of all strains.
GTP and PABA are the building blocks of folate biosynthesis. The former comes from the biosynthesis of purines, while the latter is produced through the shikimate pathway (10, 24). It has already been demonstrated that the addition of PABA at concentrations ranging between 1 and 100 µM results in an increase in folate production by Lactobacillus casei and Lactococcus lactis (23). In this study, bifidobacteria were cultured with different PABA concentrations, in a range between 0 and 100 mM, in order to evaluate the effects on growth and folate yield. For all tested bifidobacteria, the highest biomass yield was obtained at 0.3 mM PABA, while growth was inhibited when the PABA concentration was increased to 100 mM. Furthermore, folate production was generally maximal at 0.3 mM PABA and decreased with increasing PABA concentrations. In contrast to the other strains tested, increased PABA concentrations did not significantly decrease folate biosynthesis by B. adolescentis MB 239.
Folate production by B. adolescentis MB 239 was studied in depth with batch and chemostat experiments. As expected, production was growth associated, in agreement with previous studies (15). Batch fermentations were carried out at different pHs, in a range from 5.7 to 6.9, chosen to resemble the pH range of the colonic environment. No statistically significant differences in folate production were observed as a function of the pH. Hence, the probiotic strain B. adolescentis MB 239 may be effective as a folate producer in the intestinal pH range.
Oligosaccharides are effective energy and carbon sources for the growth of intestinal bifidobacteria (19). Previous studies demonstrated that B. adolescentis MB 239 grows well on the most important prebiotic carbohydrates, including
- and ß-galactosides and ß-fructosides (1). A comparison of folate production on raffinose, lactose, fructo-oligosaccharides, and their constitutive moieties was established. Folate was produced on all of the carbohydrates tested, and yields were not affected by the carbon sources. Therefore, the contribution of this strain to intestinal folate bioavailability may further increase in symbiotic nutritional supplements comprised of prebiotics.
The contribution of B. adolescentis MB 239 to folate concentration in the colonic environment was simulated in fecal cultures. As the folate concentration increased from 27 to 54 ng ml1 after a 48-h incubation, the potential efficacy of B. adolescentis MB 239 as a folate producer was demonstrated. This result suggests that in-depth in vivo studies are required, because in our experimental design fecal material was pasteurized in order to prevent folate production and absorption by other fecal bacteria and to evaluate the net contribution of B. adolescentis MB 239.
The observation that the level of folate produced by B. adolescentis MB 239 is not influenced by the exogenous folate or PABA concentrations, pH, or carbohydrate, as well as the folate production observed in fecal cultures, suggests that B. adolescentis MB 239 is an excellent prospect for use as a folate-producing strain in probiotic and symbiotic supplements. The presence in the colon of a such probiotic strain producing 50 ng/ml of folic acid, independently of the external concentration, could continuously and contiguously supply the proliferating colonocytes with this vitamin.
Our study provides new perspectives on the specific uses of probiotics, such as to prevent the localized folate deficiency that is associated with premalignant changes in the colonic epithelia. The oral administration of folate-producing probiotic strains may more efficiently confer protection against inflammation and cancer, both by exerting the beneficial effects of bifidobacteria and by delivering folate to colonic-rectal cells.
Published ahead of print on 27 October 2006. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»